Blue Water Acquisition Corp. III

General Information
Business:

We are a newly organized blank check company. (Incorporated in the Cayman Islands)

We are strategically positioned to capitalize on the immense opportunities within the biotechnology, healthcare and technology sectors. With a seasoned team, extensive industry experience and a disciplined investment approach, we are committed to creating value for our investors while fostering the next generation of industry leaders.

The biotechnology and healthcare sectors are experiencing rapid growth fueled by innovations in drug discovery, personalized medicine, medical devices and telemedicine. We intend to target companies that are leading the charge in developing groundbreaking therapies, diagnostic tools and health technology solutions. Key areas of focus include:

  Pharmaceutical Development: We intend to seek investments in companies with promising drug pipelines aimed at addressing unmet medical needs.

 

  Medical Devices: Our strategy includes supporting the development of advanced devices that enhance patient outcomes and streamline healthcare delivery.

 

  Telemedicine: We aim to enhance healthcare accessibility through digital health platforms and remote monitoring solutions.

 

  Health Tech Innovations: Our focus encompasses advancements in AI-driven diagnostics, wearable health technologies, and health data analytics.

The technology sector remains a critical driver of economic growth and innovation. Our investment strategy is centered on companies that are revolutionizing industries through advanced technological solutions. Key areas of interest include:

  Artificial Intelligence and Machine Learning: We intend to invest in AI-driven companies that offer transformative solutions across multiple sectors.

 

  Cloud Computing: Our focus includes businesses that provide scalable and efficient cloud infrastructure and services.

 

  Cybersecurity: We prioritize investments in companies developing cutting-edge cybersecurity solutions to enhance digital security.

 

  Enterprise Software Solutions: Our strategy supports software companies that enhance business efficiency, productivity and decision-making.

Our management team is made up of seasoned professionals with extensive experience across the biotechnology, healthcare and technology sectors:

*Joseph Hernandez, our chairman and CEO since inception, is an entrepreneurial leader with over 25 years of experience in the healthcare field. He is the founder of Blue Water Venture Partners, LLC, an investment firm, where he is also the senior managing partner. Along with Blue Water Venture Partners, LLC, Mr. Hernandez is the chairman and founder of several other biotechnology companies, including Perseus Therapeutics, Inc., spun out of Duke University and focused on developing novel therapies for preventing hair loss in chemotherapy-treated cancer patients and for cosmetic use; Temple Street Biotech, Inc., focused on advancing Alzheimer’s disease treatments; Eternity Biotech, spun out of Yale University and committed to developing advancements in life extension, and Energia Power Systems, Inc., spun out of Stanford University, a novel battery company. 

Martha F. Ross, a CPA, is our CFO. She brings over 25 years of global financial, strategic growth and accounting leadership experience in tech, manufacturing, communications and electric power generation, including expertise in various government funded and regulated industries. From 2020 to present, she has served as the CEO of CFO, COO and BPI Consulting, specializing in helping high-growth, high-change organizations scale from pre-IPO to publicly traded, with mergers, reorganizations and significant business model or enterprise system changes. Clients have included for profit and nonprofit clients in healthcare, logistics, education, utilities and multifamily real estate. During this time, she also served as chief financial officer of Clean Earth Acquisitions Corp., a special purpose acquisition company that completed its $230 million initial public offering in February 2022 and consummated a business combination with Alternus Energy Group in December 2023. 

(Note: Blue Water Acquisition Corp. III filed its S-1 for its SPAC IPO on Feb. 19, 2025, and disclosed the terms: 20.0 million units at $10.00 each to raise $200.0 million. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant.)

Industry: BLANK CHECKS
Employees: 0
Founded: 2024
Contact Information
Address 15 E. Putnam Avenue Suite 363 Greenwich, CT 06830
Phone Number (203) 489-2110
Web Address
View Prospectus: Blue Water Acquisition Corp. III
Financial Information
Market Cap $256.0mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol BLUWU
Exchange NASDAQ
Shares (millions): 20.0
Price range $10.00 - $10.00
Est. $ Volume $200.0 mil
Manager / Joint Managers BTIG
CO-Managers
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change